Gm11444tm2e(KOMP)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Gm11444tm2e(KOMP)Wtsi |
| Name: |
predicted gene 11444; targeted mutation 2e, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:4841390 |
| Gene: |
Gm11444 Location: Chr11:85737331-85741202 bp, - strand Genetic Position: Chr11, 51.34 cM
|
| IMPC: |
Gm11444 gene page |
|
| Mutant Cell Lines: |
EPD0655_1_A08, EPD0655_1_B08, EPD0655_1_C05, EPD0655_1_C08, EPD0655_1_D05, EPD0655_1_D07, EPD0655_1_E06, EPD0655_1_F05, EPD0655_1_F06, EPD0655_1_G06, EPD0655_1_G07, EPD0655_1_H07, EPD0657_3_A09, EPD0657_3_A11, EPD0657_3_B12, EPD0657_3_C10, EPD0657_3_E10, EPD0657_3_F09 |
| Germline Transmission: |
Unknown
|
| Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
| Strain of Origin: |
C57BL/6N-Atm1Brd
|
| Project Collection: |
KOMP-CSD
|
|
| Allele Type: |
|
Targeted (Null/knockout, Reporter) |
| Mutation: |
|
Insertion
Vector: L1L2_Bact_P
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 85739478 of Chromosome 11 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. Insertion of this cassette creates a reporter knockout mouse. Cre expression will remove the neomycin selection cassette. Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml
(J:148605, J:173534)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Gm11444 Mutation: |
12 strains or lines available
|
|
| Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
| All: |
2 reference(s) |
|